In the February 2015 issue of Medical Marketing & Media, the publication reviews the continuing trend of the growth of new products for rare diseases, reviews what rare disease products are on the horizon for 2015, and discusses the growth and popularity of gene therapy for the treatment of rare diseases. The article also identifies the top 25 orphan drug brands by worldwide sales. By 2020, per the article (according to data from EvaluatePharma), “orphan drugs will own 19% of the total share of prescription drug sales excluding generics, reaching a whopping $176 billion in annual sales”.
The following chart shows the top 10 of the 25 rare disease products ranked by 2014 global sales :
Top 10 Rare Disease Drugs By Global Sales
|Rank||Product||Manufacturer||US Sales($ Millions) *|
View original post 74 more words